Keywords
Irritable bowel syndrome
Cognitive-behavioral therapy
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To evaluate the effectiveness of cognitive-behavioral therapy (CBT) in controlling the symptoms of Irritable Bowel Syndrome. Methods: An integrative literature review was conducted by searching the PubMed, SciELO, and LILACS databases from 2013 to 2023. Randomized clinical trials with adults diagnosed with IBS who underwent CBT were included. The selection was conducted by two independent reviewers, with the help of the Rayyan platform, following the PRISMA criteria. Methodological quality was assessed using the Jadad scale. Nine studies were included in the final analysis. Results: Significant improvement in gastrointestinal symptoms, reduction of anxiety and depression, and increase in patients' quality of life were observed. The benefits were reported in both face-to-face and online therapies, with effects maintained for up to one year. CBT has proven to be a safe and effective intervention, despite the heterogeneity between studies and the lack of standardization in the protocols and instruments used. Furthermore, patients reported greater autonomy in managing symptoms and better adaptation to stressful situations. The data also suggest that the therapeutic alliance plays a relevant role in the positive results of the intervention. Final considerations: CBT contributes positively to the management of IBS and improves the well-being of patients.
References
BASNAYAKE C, et al. Cognitive Behavioral Therapy and Mindfulness in the Treatment of Irritable Bowel Syndrome: A Review of the Literature. Journal of Psychosomatic Research, 2020; v. 131, n. 1.
BASNAYAKE C, et al. Gastroenterologista padrão versus tratamento multidisciplinar para distúrbios gastrointestinais funcionais (MANTRA): um ensaio clínico controlado randomizado, aberto e de centro único. Lancet Gastroenterology Hepatology, 2020; v. 5, n.1, p. 890-899.
BLACK CJ. Epidemiological, clinical, and psychological characteristics of individuals with self-reported irritable bowel syndrome based on the Rome IV vs Rome III criteria. Clinical Gastroenterology Hepatology, 2020; v. 18, n. 2, p. 392–398.
BONNERT M, et al. Efficacy of Internet-Based Cognitive Behavioral Therapy for Adolescents with Irritable Bowel Syndrome: A Randomized Controlled Trial. Journal of Pediatric Gastroenterology and Nutrition, 2017; v. 64, n. 4, p. 604-611.
CRANER R, et al. Catastrophizing and Cognitive-Emotional Factors in the Treatment of Irritable Bowel Syndrome. Journal of Clinical Psychology in Medical Settings, 2020; v. 27, n. 4, p. 459-470.
DEHKORDI AH, SOLATI K. The Effectiveness of Cognitive Behavioral Therapy in Women with Irritable Bowel Syndrome: A Systematic Review. International Journal of Women’s Health, 2017; v. 9, n. 1, p. 19-27.
DROSSMAN DA, et al. The Role of Psychosocial Factors in the Treatment of Irritable Bowel Syndrome. American Journal of Gastroenterology, 2007; v. 102, n. 2, p. 294-306.
DROSSMAN DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterology, 2016; v. 150, n. 1, p. 1262-1279.
EVERITT HA, et al. Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial. Lancet Gastroenterol Hepatology, 2019; v. 4, n. 11, p. 863-872.
EVERITT HA, et al. Therapist telephone-delivered CBT andweb-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT. Health Technology Assessory, 2019; v. 23, n. 17, p. 1-154.
FARMER AD, et al. An approach to the care of patients with irritable bowel syndrome. CMAJ (Canadian Medical Association Journal), 2020; v. 192, n. 11, p. 275-282.
GROS DF, et al. Frequency and severity of the symptoms of irritable bowel syndrome across the anxiety disorders and depression. Journal of Anxiety Disorders, 2009; v. 23, n. 1, p. 290–296.
HENRICH JF. A randomized clinical trial of mindfulness-based cognitive therapy for women with irritable bowel syndrome-Effects and mechanisms. Journal of Consult Clinical Psychology, 2020; v. 88, n. 4, p. 295–310.
HIGGINS J. Cochrane Handbook for Systematic Reviews of Interventions version 6.5. 2 ed. Chichester. Cochrane, 2019.
HUNT SJ, et al. A Randomized Controlled Trial of Internet-Based Cognitive Behavioral Therapy for Irritable Bowel Syndrome. American Journal of Gastroenterology, 2021; v. 116, n. 5, p. 946-953.
JADAD AR, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Controlled Clinical Trials, 1996, 17(1), 1-12.
KIKUCHI M, et al. Effectiveness of Cognitive Behavioral Therapy in Patients with Refractory Irritable Bowel Syndrome. Digestive Diseases and Sciences, 2022; v. 67, n. 4, p. 1481-1488.
LACKNER JM, JACCARD J. Mechanisms of Cognitive Behavioral Therapy in the Treatment of Irritable Bowel Syndrome. American Journal of Gastroenterology, 2021; v. 116, n. 3, p. 437-444.
LIU J, et al. Low-FODMAP Diet for Irritable Bowel Syndrome: What We Know and What We Have Yet to Learn. Annual Review of Medicine, 2020; v. 71, n. 1, p. 303–314.
LONGSTREATH GF, et al. Functional Bowel Disorders. Gastroenterology, 2006; v. 130, n. 5, p. 1480-1491.
OKA P, et al. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. The Lancet Gastroenterology and Hepatology, 2020; v. 5, n. 10, p. 908–917.
OLIVER RL, TALLEY NJ. The Impact of Group Cognitive Behavioral Therapy for Irritable Bowel Syndrome: A Randomized Controlled Trial. Alimentary Pharmacology & Therapeutics, 2022; v. 56, n. 2, p. 244-253.
OUAZZANI M, et al. Rayyan—a web and mobile app for systematic reviews. Systematic Reviews, 2016; v. 5, n. 210, 1-10.
PAGE MJ, et al. A declaração PRISMA 2020: diretriz atualizada para relatar revisões sistemáticas. Epidemiologia e Serviços de Saúde, 2022; v. 31, n. 2, p. 1-20.
SAHA L. Irritable bowel syndrome: Pathogenesis, diagnosis, treatment, and evidence-based medicine. World Journal of Gastroenterology, 2014; v. 20, n. 22, p. 6759–6773.
SHAH E, et al. Mindfulness-Based Cognitive Behavioral Therapy for the Treatment of Irritable Bowel Syndrome: A Systematic Review. Digestive Diseases and Sciences, 2020; v. 65, n. 7, p. 1880-1890.
SHARMA N, SRIVASTAV AK, SAMUEL AJ. Randomized clinical trial: gold standard of experimental designs - importance, advantages, disadvantages and prejudices. Revista Pesquisa em Fisioterapia, 2020; v. 10, n. 3, p. 512–519.
SOARES AB, et al. Terapia Cognitivo Comportamental: o que pensam os estudantes de Psicologia ?. Revista Brasileira de Terapias Cognitivas, 2020; v. 16, n. 2, p. 99-106.
SPERBER AD, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation global study. Gastroenterology, 2021; v. 160, n. 1, p. 99–114.
SUGAYA N. Work-related problems and the psychosocial characteristics of individuals with irritable bowel syndrome: an updated literature review. BioPsychoSocial Medicine, 2024; v.18, n. 12, p. 1-10.
VASANT DH, et al. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut, 2021; v. 70, n. 7, p. 1214–1240.
WEAVER KR, et al. Irritable Bowel Syndrome: A review. The American Journal of Nursing, 2017; v. 117, n. 6, p. 48–55.
WILSON S. Prevalence of irritable bowel syndrome: a community survey. British Journal of General Practice, 2004; v. 54, n. 504, p. 495-502.